跳至主要内容
临床试验/JPRN-UMIN000003242
JPRN-UMIN000003242招募中未知

Docetaxel therapy for angiosarcoma(Stewart-Treves syndrome) - Docetaxel for Stewart-Treves syndrome

Department of Dermatology Ehime University School of Medicine0 个研究点目标入组 3 人开始时间: 2010年2月24日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 Allergy to Docetaxele or the component 2 Infectious disease 3 Severe liver, kidney, heart, gastro-intestinal, bone marrow injury 4 Pregnant or feeding 5 Concidered not suitable for the study

研究者

发起方
Department of Dermatology Ehime University School of Medicine

相似试验

已完成
不适用
eo adjuvant chemotherapy by Docetaxel + S-1 for resentable gasric cabcergastric cancer
JPRN-UMIN000015632Department of Frontier Surgery, Graduate school of Medicine, Chiba University20
已完成
不适用
Docetaxel and Trastuzumab therapy or maximal androgen blockade for patients with recurrent and/or metastatic salivary grand carcinomaHER2 and/or androgen receptor positive recurrent and/or metastatic salivary gland carcinoma
JPRN-UMIN000009437International University of Health and Welfare Mita Hospital30
进行中(未招募)
1 期
First Line Dose-Dense Chemotherapy With Docetaxel, Cisplatin, Folinic Acid and 5- Fluorouracil plus Panitumumab in Patients With Locally Advanced or Metastatic Cancer of the Stomach or Gastro-Esophageal Junction: A Phase II Multicentre Trial - GOIRC 02/2009Patients with metastatic or locally advanced not resectable cancer of the stomach or gastro-esophageal junction.MedDRA version: 9.1Level: PTClassification code 10017758MedDRA version: 9.1Level: HLTClassification code 10030176
EUCTR2009-016962-10-ITGRUPPO ONCOLOGICO ITALIANO DI RICERCA52
已完成
2 期
Docetaxel and S-1 as adjuvant chemotherapy for pathological stage II, IIIA, IIIB gastric cancerPathological stage II, IIIa, or IIIb gastric cancer
JPRN-UMIN000000857Dept. of Surgery and Science, Kyushu University20
已完成
1 期
PhaseI/II trial of chemotherapy with docetaxel, CDDP and 5-Fluorouracil followed by chemoradiotherapy with CDDP and 5-Fluorouracil in patients with locally advanced esophageal cancer.esophageal cancer
JPRN-UMIN000003546Department of Surgical Oncology, Division of Clinical and Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University60